Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6)— 510(k) K252358

Substantially Equivalent

Nexstim Oyj

FDA 510(k) clearance K252358 for Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6), Substantially Equivalent on 2026-03-20. Applicant: Nexstim Oyj. Device class: 2.

Summary

Nexstim Oyj's Nexstim Navigated Brain Stimulation (NBS) 6 System (NBS6) is filed under OBP, transcranial magnetic stimulators. The record doesn't describe the system beyond its name and that code name.

Class II, 21 CFR 882.5805. Neurology is both the classification panel and the review panel, and it came in as a Traditional 510(k).

Nexstim filed from Helsinki, Finland. Review took 234 calendar days (July 29, 2025 to March 20, 2026).

Clearance details

Applicant
Nexstim Oyj
Product code
Product code OBP
Device class
Class 2
Regulation
21 CFR 882.5805
Advisory panel
Neurology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Helsinki, FI
Download summary PDFView on FDA.gov ↗

Recent devices under product code OBP

view all

More clearances from Nexstim Oyj

view all

Adverse events under product code OBP

product code OBP
Injury
270
Total
270

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.